Table 1.
Patient Demographics, Clinical Information, and Infusion Events
| Characteristic | Patients, No. (%) (N = 12 237) |
|---|---|
| Women | 9480 (77.5) |
| Men | 2757 (22.5) |
| Age at time of infusion, mean (SD), y | 51 (20) |
| Documented history of allergya | 9677 (79.1) |
| Race | |
| American Indian/Alaska Native | 119 (1.0) |
| Asian | 338 (2.8) |
| Black | 717 (5.9) |
| White | 10 250 (83.7) |
| Unknown, declined, or otherb | 813 (6.6) |
| Ethnicity | |
| Hispanic | 1026 (8.4) |
| Non-Hispanic | 10 161 (83.0) |
| Unknown or declined | 1050 (8.6) |
| Total iron infusion events, No. | 35 737 |
| Iron sucrose | 22 309 (62.4) |
| Iron dextran full dose (with or without test) | 9011 (25.2) |
| Iron dextran test alone | 56 (0.2) |
| Ferumoxytol | 3147 (8.8) |
| Ferric carboxymaltose | 1214 (3.4) |
a
Inclusive of allergy to medication, food, or contact allergies.
b
Data were not captured for specific race categories included in the other race category, which were limited to the electronic health record inputs.